Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Oct;68(4):668–672. doi: 10.1038/bjc.1993.406

The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma.

T Hickish 1, D Cunningham 1, K Colston 1, B C Millar 1, J Sandle 1, A G Mackay 1, M Soukop 1, J Sloane 1
PMCID: PMC1968598  PMID: 8398690

Abstract

1,25(OH)2D3 promotes differentiation and has an antiproliferative effect in a variety of cell lines derived from the immunohaematopoetic system. alpha-Calcidol which is metabolised to 1,25(OH)2D3 has been shown to produce tumour regression in follicular low grade non-Hodgkin's lymphoma (NHL) and the dose limiting toxicity is hypercalcaemia. The cellular action of 1,25(OH)2D3 is mediated by binding to an intracellular protein, the vitamin D receptor (VDR). We have evaluated the activity of 1,25(OH)2D3 and its non-calcaemogenic analogue MC903 in the SU-DHL4 and SU-DUL5 B cell lines which carry the 14;18 translocation characteristic of follicular NHL, and also the expression of the VDR in a range of B cell NHLs. Both agents induced differentiation and had an antiproliferative effect on the SU-DHL4 and SU-DUL5 cell lines. However this occurred at a relatively high concentration (10(-7) M) which exceeds the physiological concentration of 1,25(OH)2D3 by approximately 10(3)-10(4)-fold. Expression of the VDR was low in each cell line and in the low grade lymphoma tumour samples. To account for the observed clinical response to 1 alpha OHD3 (alpha-calcidol) in follicular NHL a network is suggested whereby 1,25(OH)2D3 modulates the activity of CD4+T cells which have previously been shown to promote follicle centre cell proliferation. Vitamin D3 analogues may enable serum levels to be achieved which produce a direct action on follicular lymphoma cells without disturbing calcium metabolism.

Full text

PDF
668

Images in this article

670Figure 2
on p.670

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhalla A. K., Amento E. P., Serog B., Glimcher L. H. 1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol. 1984 Oct;133(4):1748–1754. [PubMed] [Google Scholar]
  2. Bhalla A. K., Williams M. M., Lal S., Lydyard P. M. 1,25-Dihydroxyvitamin D3, but not retinoic acid, induces the differentiation of U937 cells. Clin Exp Immunol. 1989 May;76(2):274–277. [PMC free article] [PubMed] [Google Scholar]
  3. Binderup L., Bramm E. Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol. 1988 Mar 1;37(5):889–895. doi: 10.1016/0006-2952(88)90177-3. [DOI] [PubMed] [Google Scholar]
  4. Binderup L. Immunological properties of vitamin D analogues and metabolites. Biochem Pharmacol. 1992 May 8;43(9):1885–1892. doi: 10.1016/0006-2952(92)90630-2. [DOI] [PubMed] [Google Scholar]
  5. Blifeld C., Prehn J. L., Jordan S. C. Stimulus-specific 1,25(OH)2D3 modulation of TNF and IL-1-beta gene expression in human peripheral blood mononuclear cells and monocytoid cell lines. Transplantation. 1991 Feb;51(2):498–503. doi: 10.1097/00007890-199102000-00043. [DOI] [PubMed] [Google Scholar]
  6. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  7. Chen T. L., Li J. M., Ye T. V., Cone C. M., Feldman D. Hormonal responses to 1,25-dihydroxyvitamin D3 in cultured mouse osteoblast-like cells--modulation by changes in receptor level. J Cell Physiol. 1986 Jan;126(1):21–28. doi: 10.1002/jcp.1041260104. [DOI] [PubMed] [Google Scholar]
  8. Cleary M. L., Galili N., Sklar J. Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med. 1986 Jul 1;164(1):315–320. doi: 10.1084/jem.164.1.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cleary M. L., Smith S. D., Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell. 1986 Oct 10;47(1):19–28. doi: 10.1016/0092-8674(86)90362-4. [DOI] [PubMed] [Google Scholar]
  10. Colston K. W., Chander S. K., Mackay A. G., Coombes R. C. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol. 1992 Aug 18;44(4):693–702. doi: 10.1016/0006-2952(92)90405-8. [DOI] [PubMed] [Google Scholar]
  11. Colston K., Hirt M., Feldman D. Organ distribution of the cytoplasmic 1,25-dihydroxycholecalciferol receptor in various mouse tissues. Endocrinology. 1980 Dec;107(6):1916–1922. doi: 10.1210/endo-107-6-1916. [DOI] [PubMed] [Google Scholar]
  12. Dodd R. C., Cohen M. S., Newman S. L., Gray T. K. Vitamin D metabolites change the phenotype of monoblastic U937 cells. Proc Natl Acad Sci U S A. 1983 Dec;80(24):7538–7541. doi: 10.1073/pnas.80.24.7538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Iho S., Takahashi T., Kura F., Sugiyama H., Hoshino T. The effect of 1,25-dihydroxyvitamin D3 on in vitro immunoglobulin production in human B cells. J Immunol. 1986 Jun 15;136(12):4427–4431. [PubMed] [Google Scholar]
  14. Jordan S. C., Lemire J. M., Sakai R. S., Toyoda M., Adams J. S. Exogenous interleukin-2 does not reverse the immunoinhibitory effects of 1,25-dihydroxyvitamin D3 on human peripheral blood lymphocyte immunoglobulin production. Mol Immunol. 1990 Jan;27(1):95–100. doi: 10.1016/0161-5890(90)90064-7. [DOI] [PubMed] [Google Scholar]
  15. Kizaki M., Norman A. W., Bishop J. E., Lin C. W., Karmakar A., Koeffler H. P. 1,25-Dihydroxyvitamin D3 receptor RNA: expression in hematopoietic cells. Blood. 1991 Mar 15;77(6):1238–1247. [PubMed] [Google Scholar]
  16. Lee Y., Inaba M., DeLuca H. F., Mellon W. S. Immunological identification of 1,25-dihydroxyvitamin D3 receptors in human promyelocytic leukemic cells (HL-60) during homologous regulation. J Biol Chem. 1989 Aug 15;264(23):13701–13705. [PubMed] [Google Scholar]
  17. Mangelsdorf D. J., Koeffler H. P., Donaldson C. A., Pike J. W., Haussler M. R. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. J Cell Biol. 1984 Feb;98(2):391–398. doi: 10.1083/jcb.98.2.391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McDonnell T. J., Deane N., Platt F. M., Nunez G., Jaeger U., McKearn J. P., Korsmeyer S. J. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 1989 Apr 7;57(1):79–88. doi: 10.1016/0092-8674(89)90174-8. [DOI] [PubMed] [Google Scholar]
  19. Moore D. C., Carter D. L., Bhandal A. K., Studzinski G. P. Inhibition by 1,25 dihydroxyvitamin D3 of chemically induced erythroid differentiation of K562 leukemia cells. Blood. 1991 Apr 1;77(7):1452–1461. [PubMed] [Google Scholar]
  20. Norman A. W., Zhou J. Y., Henry H. L., Uskokovic M. R., Koeffler H. P. Structure-function studies on analogues of 1 alpha,25-dihydroxyvitamin D3: differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. Cancer Res. 1990 Nov 1;50(21):6857–6864. [PubMed] [Google Scholar]
  21. Raina V., Cunningham D., Gilchrist N., Soukop M. Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer. 1991 Mar;63(3):463–465. doi: 10.1038/bjc.1991.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rebel V. I., Ossenkoppele G. J., van de Loosdrecht A. A., Wijermans P. W., Beelen R. H., Langenhuijsen M. M. Monocytic differentiation induction of HL-60 cells by MC 903, a novel vitamin D analogue. Leuk Res. 1992;16(5):443–451. doi: 10.1016/0145-2126(92)90169-8. [DOI] [PubMed] [Google Scholar]
  23. Reichel H., Koeffler H. P., Norman A. W. The role of the vitamin D endocrine system in health and disease. N Engl J Med. 1989 Apr 13;320(15):980–991. doi: 10.1056/NEJM198904133201506. [DOI] [PubMed] [Google Scholar]
  24. Rigby W. F., Denome S., Fanger M. W. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest. 1987 Jun;79(6):1659–1664. doi: 10.1172/JCI113004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Rigby W. F. The immunobiology of vitamin D. Immunol Today. 1988 Feb;9(2):54–58. [PubMed] [Google Scholar]
  26. Strom M., Sandgren M. E., Brown T. A., DeLuca H. F. 1,25-Dihydroxyvitamin D3 up-regulates the 1,25-dihydroxyvitamin D3 receptor in vivo. Proc Natl Acad Sci U S A. 1989 Dec;86(24):9770–9773. doi: 10.1073/pnas.86.24.9770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Tsoukas C. D., Provvedini D. M., Manolagas S. C. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science. 1984 Jun 29;224(4656):1438–1440. doi: 10.1126/science.6427926. [DOI] [PubMed] [Google Scholar]
  28. Tsoukas C. D., Watry D., Escobar S. S., Provvedini D. M., Dinarello C. A., Hustmyer F. G., Manolagas S. C. Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab. 1989 Jul;69(1):127–133. doi: 10.1210/jcem-69-1-127. [DOI] [PubMed] [Google Scholar]
  29. Umetsu D. T., Esserman L., Donlon T. A., DeKruyff R. H., Levy R. Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J Immunol. 1990 Apr 1;144(7):2550–2557. [PubMed] [Google Scholar]
  30. Weiss L. M., Warnke R. A., Sklar J., Cleary M. L. Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med. 1987 Nov 5;317(19):1185–1189. doi: 10.1056/NEJM198711053171904. [DOI] [PubMed] [Google Scholar]
  31. Yunis J. J., Frizzera G., Oken M. M., McKenna J., Theologides A., Arnesen M. Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer. N Engl J Med. 1987 Jan 8;316(2):79–84. doi: 10.1056/NEJM198701083160204. [DOI] [PubMed] [Google Scholar]
  32. Zhou J. Y., Norman A. W., Lübbert M., Collins E. D., Uskokovic M. R., Koeffler H. P. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization. Blood. 1989 Jul;74(1):82–93. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES